ArticleOne health (Amsterdam, Netherlands)2026
Screening for alveolar echinococcosis in household members of affected patients: A cross-sectional study with a pooled comparison to endemic population screenings.
Article in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alveolar echinococcosis (AE) is an emerging and potentially fatal zoonosis caused by accidental ingestion of infective eggs of the cestode Methods: We conducted a cross-sectional study at the University Hospital of Ulm, Germany. Unrelated household members of AE patients who shared the same household for ≥5 years prior to the patient's diagnosis were invited for screening with serological testing and abdominal ultrasound. The primary endpoint was the prevalence of possible or probable AE. Results: A total of 100 household members from 100 AE patients were recruited. Six participants showed positive or borderline results in one of the two serological tests, but none showed positivity in both and all had negative western blot results. Of the 88 participants with available imaging, only one participant had a calcified, inactive AE lesion, classified as possible AE. No participant met the criteria for probable AE. Conclusion: We observed a higher seroprevalence (6.0%) among household members than pooled estimates from population-based screenings in high-endemic areas (1.9%; 95% CI 1.6-2.1%). The prevalence of inactive AE (1136 per 100,000) also exceeded that reported in these studies (51 per 100,000; 95% CI 22-101); however, the sample size and a different screening approach limit the comparability of the findings. Importantly, AE remained rare in this group, and no clinically relevant active cases were detected. Although exposure to infective EM eggs may be increased among household members, host-related factors may influence whether infection becomes clinically manifest. Based on these results, routine screening of unrelated household members cannot be recommended at this time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.